|
GB9720465D0
(en)
|
1997-09-25 |
1997-11-26 |
Oxford Biomedica Ltd |
Dual-virus vectors
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
EP1224313A1
(en)
|
1999-10-07 |
2002-07-24 |
University of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
|
AU7895700A
(en)
|
1999-10-15 |
2001-04-30 |
Dalhousie University |
Method and vector for producing and transferring trans-spliced peptides
|
|
AU4445701A
(en)
|
2000-03-24 |
2001-10-03 |
Centre National De La Recherche Scientifique-Cnrs |
Multiple human and mouse otoferlin isoforms
|
|
US20040072154A1
(en)
|
2000-12-22 |
2004-04-15 |
Morris David W. |
Novel compositions and methods for cancer
|
|
WO2002082904A2
(en)
*
|
2001-04-13 |
2002-10-24 |
The Trustees Of The University Of Pennsylvania |
Method of treating or retarding the development of blindness
|
|
JP2003088388A
(ja)
|
2001-09-14 |
2003-03-25 |
Herikkusu Kenkyusho:Kk |
新規な全長ｃＤＮＡ
|
|
CN1934260B
(zh)
|
2004-01-22 |
2013-03-13 |
株式会社载体研究所 |
利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
|
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
WO2007127428A2
(en)
|
2006-04-28 |
2007-11-08 |
University Of Florida Research Foundation, Inc. |
Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
|
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
|
CN101711164B
(zh)
|
2007-01-18 |
2014-06-04 |
密苏里-哥伦比亚大学 |
可修复肌纤维膜中的神经元型一氧化氮合酶的合成小/微-抗肌萎缩蛋白基因
|
|
FR2919305B1
(fr)
|
2007-07-26 |
2009-09-18 |
Genethon Ass Loi De 1901 |
Vecteurs viraux adeno-associes pour l'expression de la dysferline.
|
|
US8188131B2
(en)
|
2008-02-07 |
2012-05-29 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance Atoh1 expression
|
|
WO2009108274A2
(en)
*
|
2008-02-26 |
2009-09-03 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for adeno-associated virus (aav) with hi loop mutations
|
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
WO2010062905A2
(en)
|
2008-11-26 |
2010-06-03 |
The Regents Of The University Of California |
Lateral ventricle cell compositions and use for treating neural degenerative diseases
|
|
SG10201800541SA
(en)
|
2010-04-23 |
2018-03-28 |
Univ Florida |
Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
MX367100B
(es)
*
|
2012-02-17 |
2019-08-05 |
The Children´S Hospital Of Philadelphia |
Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
NZ701693A
(en)
|
2012-04-18 |
2017-02-24 |
The Children’S Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
|
US20150209406A1
(en)
|
2012-09-07 |
2015-07-30 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for regenerating hair cells and/or supporting cells
|
|
EP2970972B1
(en)
|
2013-03-11 |
2018-08-15 |
Fondazione Telethon |
Mir-204 and mir-211 and uses thereof
|
|
AU2014255665B2
(en)
|
2013-04-18 |
2018-08-02 |
Fondazione Telethon |
Effective delivery of large genes by dual AAV vectors
|
|
EP3492597A3
(en)
|
2013-05-21 |
2019-08-28 |
University of Florida Research Foundation, Inc. |
Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer
|
|
US11000597B2
(en)
|
2015-01-21 |
2021-05-11 |
University Of Florida Research Foundation, Incorporated |
Engineered receptor/ligand system for delivery of therapeutic agents
|
|
EP3258955A1
(en)
|
2015-02-20 |
2017-12-27 |
Institut Pasteur |
Prevention and/or treatment of hearing loss or impairment
|
|
SI3265571T1
(sl)
|
2015-03-03 |
2022-10-28 |
Fondazione Telethon |
Več vektorski sistem in njegove uporabe
|
|
AU2016324317A1
(en)
|
2015-09-17 |
2018-03-08 |
Coda Biotherapeutics, Inc. |
Compositions and methods for treating neurological disorders
|
|
SG10201913266UA
(en)
*
|
2015-12-11 |
2020-02-27 |
Massachusetts Eye & Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
JP7007273B2
(ja)
|
2015-12-22 |
2022-01-24 |
アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） |
遺伝子治療用の改良された複合型二重組換えａａｖベクターシステム
|
|
EP3472328A1
(en)
|
2016-06-15 |
2019-04-24 |
Oxford University Innovation Limited |
Dual overlapping adeno-associated viral vector system for expressing abc4a
|
|
EP3510161A4
(en)
*
|
2016-08-23 |
2020-04-22 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
|
|
WO2018145111A1
(en)
|
2017-02-06 |
2018-08-09 |
Children's Medical Center Corporation |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
WO2018162748A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
KR102606810B1
(ko)
|
2017-05-05 |
2023-11-27 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
오토펄린을 발현시키기 위한 조성물 및 방법
|
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
IL325122A
(en)
*
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
US20190345516A1
(en)
*
|
2018-03-12 |
2019-11-14 |
Musc Foundation For Research Development |
Methods for treating eye disease
|
|
BR112020019079A2
(pt)
|
2018-03-23 |
2020-12-29 |
Massachusetts Eye And Ear Infirmary |
Abordagem de salto de éxon mediada por crispr/cas9 para síndrome de usher associada a ush2a
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN112703016B
(zh)
*
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
WO2020093018A1
(en)
*
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
EP4063510A1
(en)
|
2018-11-07 |
2022-09-28 |
Akouos, Inc. |
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
|
SG11202107645RA
(en)
|
2019-01-18 |
2021-08-30 |
Voyager Therapeutics Inc |
Methods and systems for producing aav particles
|
|
EP4295913A3
(en)
|
2019-01-18 |
2024-03-06 |
Institut Pasteur |
Aav-mediated gene therapy restoring the otoferlin gene
|
|
EP3921032A4
(en)
*
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
CA3129422A1
(en)
*
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
KR20220130093A
(ko)
|
2019-10-30 |
2022-09-26 |
데시벨 테라퓨틱스, 인크. |
오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 조성물 및 방법
|
|
KR20220157944A
(ko)
|
2020-02-21 |
2022-11-29 |
아카우오스, 인크. |
인간 대상체에서 비-연령-연관 청각 장애를 치료하기 위한 조성물 및 방법
|
|
CN115666658A
(zh)
|
2020-04-01 |
2023-01-31 |
佛罗里达州大学研究基金会 |
具有提高的治疗ush1b的安全性的双aav-myo7a载体
|
|
EP4294460A4
(en)
|
2021-02-19 |
2025-06-25 |
Decibel Therapeutics, Inc. |
Methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
IL322655A
(en)
|
2023-02-17 |
2025-10-01 |
Decibel Therapeutics Inc |
Method and compositions for administering a dual autopralin vector system
|